SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-22
👔
Serina Therapeutics, Inc.
@SER_InsiderForm 4 Filing: Venkatesan Jay Acquires $505,390.42 of $SER
INSIDER ACQUISITION
⚡ MATERIALITY: 3/10
corporate issuer
Serina Therapeutics, Inc.
Ticker: $SER
Transaction Value
$505,390.42
Price/Share: $2.25
transaction date
2026-06-17
Shares: 224,741
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Venkatesan Jay, holds the title of Director at Serina Therapeutics, Inc..
On 2026-06-17, the insider transacted 224,741 shares.The shares were transacted at a weighted average price of $2.25 per share, resulting in a total market-relevant value of $505,390.42.
Executive Summary Summary
Venkatesan Jay (Director) transacted $505K of $SER
Post-Transaction Position: 231,705 shares
SEC Accession No: 0001413350-26-000004 (CIK: 1413350)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.